Target intelligence / Profile preview

Influenza A virus hemagglutinin stalk region (HA stalk) (HA stalk)

Target
HA stalk
Molecular classification
Viral surface glycoprotein, Class I fusion protein
01

Overview

The Influenza A virus hemagglutinin (HA) stalk region is a highly conserved domain of the primary viral surface glycoprotein responsible for mediating host cell entry (Krammer & Palese, 2015, Nature Reviews Drug Discovery). While the globular head of HA (HA1) undergoes frequent antigenic drift, the stalk region (primarily HA2) remains relatively stable across diverse influenza subtypes, making it a critical target for the development of universal influenza vaccines and broad-spectrum therapeutics (Ekiert et al., 2009, Science). The biological function of the stalk is to facilitate the fusion of the viral envelope with the host endosomal membrane; this process is triggered by the acidic environment of the endosome, which induces a massive "spring-loaded" conformational change in the stalk (UniProt P03437). Therapeutic interventions, including monoclonal antibodies like CR6261 and MEDI8852, as well as small molecules like Umifenovir, bind to this region to stabilize the pre-fusion state and prevent the structural transition required for membrane fusion (Dreyfus et al., 2012, Science). By blocking this essential step in the viral life cycle, these agents provide broad protection against multiple strains of Influenza A, addressing the limitations of traditional seasonal vaccines. This target is particularly valuable because it offers a path toward a "universal" vaccine that would not require annual reformulation, although challenges such as the lower immunogenicity of the stalk compared to the head must be overcome (Impagliazzo et al., 2015, Science).

Other names
HA stemHemagglutinin stem regionHA2 subunitConserved HA stalk domain
02

Mechanism of action

Inhibition of pH-dependent conformational change and membrane fusion

03

Biological functions

Viral entryMembrane fusionpH-dependent conformational change
04

Disease associations

Infection
05

Safety considerations

Antibody-dependent enhancement (ADE)Viral escape mutantsLow immunogenicity of the stalk domain
06

Interacting drugs

Umifenovir

8 more in the full profile.

07

Biomarkers

Anti-stalk antibody titerStalk-specific ELISAMicroneutralization assay

Beyond the preview

Go deeper on Influenza A virus hemagglutinin stalk region (HA stalk) (HA stalk).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus hemagglutinin stalk region (HA stalk) (HA stalk).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call